Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer

NCT00083174 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

4560

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: exemestane

Sponsor

NCIC Clinical Trials Group

Collaborators

[object Object]
[object Object]